Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss

Summary

Autologous human bone marrow mononuclear fraction (BMMF) will be harvested and given to children with bilateral moderate to severe sensorineural hearing loss. The aim is to determine if bone marrow mononuclear fraction (BMMF) infusion is safe, feasible, improves inner ear function, audition, and language development.

Timeline

Start

2015-10

Primary completion

2022-09

Completion

2022-09

Outcome

Outcome not reported

Stopped: “Restructuring Cell Lab”

Drugs

Indications